Page last updated: 2024-09-04

levofloxacin and Mycoses

levofloxacin has been researched along with Mycoses in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Frauenfelder, T; Gerber, B; Köppel, J; Manz, MG; Nair, G; Nguyen-Kim, TD; Paul, M; Schanz, U	1
Couderc, L; Lémée, L; Marguet, C; Morisse-Pradier, H	1
Estes, LL; Wilson, JW; Zeuli, JD	1

Reviews

1 review(s) available for levofloxacin and Mycoses

Article	Year
[Infections in cystic fibrosis: Up-to-date]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2016, Volume: 23, Issue:12S Topics: Child; Cystic Fibrosis; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Early Diagnosis; Early Medical Intervention; Guideline Adherence; Humans; Infant; Levofloxacin; Mycoses; Opportunistic Infections; Respiratory Tract Infections; Treatment Outcome	2016

Article

Year

[Infections in cystic fibrosis: Up-to-date].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2016, Volume: 23, Issue:12S

Topics: Child; Cystic Fibrosis; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Early Diagnosis; Early Medical Intervention; Guideline Adherence; Humans; Infant; Levofloxacin; Mycoses; Opportunistic Infections; Respiratory Tract Infections; Treatment Outcome

2016

Other Studies

2 other study(ies) available for levofloxacin and Mycoses

Article	Year
Efficacy of anti-fungal but not anti-bacterial prophylaxis in intensive primary AML therapy: a real-world, retrospective comparative single-centre study. Swiss medical weekly, 2014, Volume: 144 Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Bacteremia; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Levofloxacin; Male; Middle Aged; Mycoses; Retrospective Studies; Survival Rate; Triazoles	2014
Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:3 Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Fluconazole; Hematologic Neoplasms; Humans; Hypokalemia; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Mycoses; Ofloxacin; Pyrimidines; Risk Factors; Torsades de Pointes; Triazoles; Ventricular Dysfunction, Left; Voriconazole	2013

Article

Year

Efficacy of anti-fungal but not anti-bacterial prophylaxis in intensive primary AML therapy: a real-world, retrospective comparative single-centre study.

Swiss medical weekly, 2014, Volume: 144

Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Bacteremia; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Levofloxacin; Male; Middle Aged; Mycoses; Retrospective Studies; Survival Rate; Triazoles

2014

Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients.

Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:3

Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Fluconazole; Hematologic Neoplasms; Humans; Hypokalemia; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Mycoses; Ofloxacin; Pyrimidines; Risk Factors; Torsades de Pointes; Triazoles; Ventricular Dysfunction, Left; Voriconazole

2013